trial
as of 2026-07-01Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy
NCTId NCT01609153
at a glance
Phase 4 · Completed
Enrollment 328 (actual)
Sponsored by Heinrich-Heine University, Duesseldorf
Primary completion 2019-04
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
328 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2012-06
Primary completion
2019-04
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Heinrich-Heine University, DuesseldorfLead Sponsor
Investigators
1
Christian Schmidt-Kraepelin, Dr.Principal Investigator
Sites
21 total
Aachen, GermanyAlzey, GermanyAndernach, GermanyAugsburg, GermanyBerlin, GermanyCologne, GermanyDortmund, GermanyDüsseldorf, GermanyGöttingen, GermanyGroß-Umstadt, GermanyGünzburg, GermanyHanover, Germany
Facts & assertions
4 sourced
Enrollment
328
Phase
PHASE4
Primary Completion Date
2019-04
Status
COMPLETED
relationships
The graph out of here
drug
drug
drug
lead_sponsor
indication
investigator